查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1358101

途径类药物市场：按药物类型、按用途、按给药给药、按配销通路、按地区

Opioid Drugs Market, by Drug Type, by Application, by Route of Administration, by Distribution Channel, and by Region
出版日期: | 出版商: Coherent Market Insights | 英文 203 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2023 年，全球鸦片类药物市场价值将达到 450 亿美元，预测期内（2023-2030 年）年复合成长率为 3.3%。

报告范围 报告详情
基准年 2022年 2023年市场规模 450亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期年复合成长率 3.30% 2030年市场规模预测 565亿美元
阿片类药物全球市场占有率(%)（按药物类别），2023 年
阿片类药物市场-IMG1

鸦片类药物是作用于鸦片受体产生吗啡样作用的物质。出于医疗目的，主要用于麻醉等止痛。其他医疗用途包括控制腹泻、阿片类药物使用疾患的替代疗法、阿片类药物过量摄取逆转和咳嗽抑制。吗啡是最早的鸦片类药物之一，于 1803 年开发出来。鸦片类药物作用于中枢和周边神经系统的鸦片受体以缓解疼痛。阿片类药物以口服锭剂、肠胃外溶液、贴片和锭剂的形式给药。处方鸦片类药物有许多不同类型，包括芬太尼、羟考酮、吗啡、可待因、羟吗啡酮和氢可酮，医生开处方主要用于治疗疼痛。

市场动态

主要市场参与者正在关注产品发布和核准等内部成长策略，预计这将在预测期内推动市场成长。此外，随着全球人口老化的增加，阿片类药物的使用预计会增加。老年人患有更多合併症，心血管疾病、关节炎和癌症等慢性疾病的风险更高。因此，老年人患病的增加预计将推动市场成长。此外，癌症、关节炎引起的慢性疼痛、腰痛、纤维肌痛和术后疼痛等慢性疾病的患病不断上升，预计也会在预测期内增加鸦片类药物作为止痛药的使用，预计将推动市场成长。例如，根据美国疾病管制与预防中心 (CDC) 2021 年 10 月发布的情况说明书，约四分之一的美国成年人 (23.7%)，即约 5850 万人，被医生诊断患有关节炎. ，预计到2045 年将达到7,800 万人。

本研究的主要特点

  • 本报告对全球阿片类药物市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和復合年度（年复合成长率）。
  • 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场促进因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球阿片类药物市场的主要企业。
  • 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
  • 全球阿片类药物市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过分析全球阿片类药物市场时所使用的各种策略矩阵，促进相关人员的决策。

目录

第1章调查目的和假设

  • 这项研究的目的
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要

第3章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 市场机会
  • 影响分析
  • 近期产品发布
  • 流行病学
  • 合併、收购和合作
  • 法规场景
  • 主要进展
  • 赎回场景
  • PEST分析
  • 波特的分析

第4章全球鸦片类药物市场，新型冠状病毒影响分析

  • 经济影响
  • 新型冠状病毒（COVID-19）的流行病学
  • 对需求和供给的影响

第5章全球鸦片类药物市场，依药物类别，2018-2030

  • 生物碱
  • 吗啡
  • 可待因
  • 半合成鸦片类药物
  • 羟考酮
  • 氢可酮
  • 氢吗啡酮
  • 合成鸦片类药物
  • 芬太尼
  • 阿芬太尼

第6章全球鸦片类药物市场，依用途，2018-2030

  • 缓解疼痛
  • 止咳药
  • 抑制腹泻

第7章全球鸦片类药物市场，依给药途径，2018-2030

  • 口服
  • 局部的
  • 胃肠外的
  • 其他（肌肉注射等）

第8章全球鸦片类药物市场，依配销通路划分，2018-2030 年

  • 医院药房
  • 零售药房
  • 网路药房

第9章全球鸦片类药物市场，按地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争形势

  • 公司简介
    • Teva Pharmaceutical Industries Ltd.
    • Johnson &Johnson
    • Endo International plc
    • Lupin Limited
    • Cadila Healthcare Limited
    • Purdue Pharma LP
    • AbbVie Inc.
    • Fresenius Kabi
    • Mallinckrodt Pharmaceuticals
    • Pfizer Inc.
    • Rhodes Pharmaceuticals LP
    • Sun Pharmaceutical Industries Limited
    • Nesher Pharmaceuticals（USA）LLC
    • Amneal Pharmaceuticals LLC
    • Trevena Inc.
    • Aurobindo Pharma Limited

第11章章节

  • 参考
  • 调查方法
简介目录
Product Code: CMI1017

The global opioid drugs market is estimated to be valued at US$ 45.0 billion in 2023 and is expected to exhibit a CAGR of 3.3% during the forecast period (2023-2030).

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 45.0 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 3.30% 2030 Value Projection: US$ 56.5 Bn
Global Opioid Drugs Market Share (%), By Drug Class, 2023
Opioid Drugs Market - IMG1

Opioids are substances that act on opioid receptors to produce morphine-like effects. Medically, they are primarily used for pain relief, including anesthesia. Other medical uses include suppression of diarrhea, replacement therapy for opioid use disorder, reversing opioid overdose, and suppressing cough. One of the first opioid drugs, 'morphine', was developed in 1803. Opioid drugs act on the opioid receptors present in the central and peripheral nervous systems, thus providing relief from pain. Opioids are administered in the form of oral pills, parenteral liquids, patches, or lozenges. There are different types of prescription opioids available, such as fentanyl, oxycodone, morphine, codeine, oxymorphone, and hydrocodone, which are prescribed by physicians for mainly treating pain.

Market Dynamics

The key market players are focused on organic growth strategies such as product launches and approval, and this is expected to drive market growth for the forecast period. Moreover, the growing geriatric population globally is expected to increase the usage of opioids, as elderly people are at high risk of chronic diseases such as cardiovascular diseases, arthritis, and cancer due to the high comorbid conditions. Thus, the rising prevalence of old people is expected to drive market growth. In addition, the increasing prevalence of chronic diseases such as cancer, chronic pain due to arthritis, lower back pain, fibromyalgia, and postsurgical pain is also expected to increase the usage of opioids as pain relieving agents, which is expected to drive market growth for the forecast period. For instance, as per the factsheet published by the Center for Disease Control and Prevention (CDC) in October 2021, about 1 in 4 U.S. adults (23.7%), or about 58.5 million people, have doctor-diagnosed arthritis, and this is expected to reach 78 million by 2045.

Key features of the study:

  • This report provides an in-depth analysis of the global opioid drugs market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global opioid drugs market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Johnson & Johnson, Endo International plc, Lupin Limited, Cadila Healthcare Limited, Purdue Pharma L.P., AbbVie Inc., Fresenius Kabi, Mallinckrodt Pharmaceuticals, Pfizer Inc., Rhodes Pharmaceuticals L.P., Sun Pharmaceutical Industries Limited, Nesher Pharmaceuticals (USA) LLC, Amneal Pharmaceuticals LLC, Trevena Inc., and Aurobindo Pharma Limited
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global opioid drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global opioid drugs market.

Opioid Drugs Market Detailed Segmentation:

  • By Drug Class:
    • Alkaloids
    • Morphine
    • Codeine
    • Semisynthetic Opioids
    • Oxycodone
    • Hydrocodone
    • Hydromorphone
    • Synthetic Opioids
    • Fentanyl
    • Alfentanil
  • By Application:
    • Analgesia
    • Cough Suppression
    • Diarrhea Suppression
  • By Route of Administration:
    • Oral
    • Topical
    • Parenteral
    • Others (Intramuscular, etc.)
  • By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.
    • Johnson & Johnson
    • Endo International plc
    • Lupin Limited
    • Cadila Healthcare Limited
    • Purdue Pharma L.P.
    • AbbVie Inc.
    • Fresenius Kabi
    • Mallinckrodt Pharmaceuticals
    • Pfizer Inc.
    • Rhodes Pharmaceuticals L.P.
    • Sun Pharmaceutical Industries Limited
    • Nesher Pharmaceuticals (USA) LLC
    • Amneal Pharmaceuticals LLC
    • Trevena Inc.
    • Aurobindo Pharma Limited

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Drug Class
    • Market Snippet, By Application
    • Market Snippet, By Route of Administration
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • Reimbursement Scenario
  • PEST Analysis
  • PORTER'S Analysis

4. Global Opioid Drugs Market-COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact on Supply and Demand

5. Global Opioid Drugs Market, By Drug Class, 2018- 2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Alkaloids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Morphine
  • codeine
  • Semisynthetic Opioids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Oxycodone
  • Hydrocodone
  • Hydromorphone
  • Synthetic Opioids
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Fentanyl
  • Alfentanil

6. Global Opioid Drugs Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Analgesia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Cough Suppression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Diarrhea Suppression
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

7. Global Opioid Drugs Market, By Route of Administration, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Parenteral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends
  • Others (Intramuscular, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
    • Segment Trends

8. Global Opioid Drugs Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Opioid Drugs Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019-2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018-2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Application, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2018 -2030, (US$ Bn)
    • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profiles
    • Teva Pharmaceutical Industries Ltd.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Strategies
    • Johnson & Johnson
    • Endo International plc
    • Lupin Limited
    • Cadila Healthcare Limited
    • Purdue Pharma L.P.
    • AbbVie Inc.
    • Fresenius Kabi
    • Mallinckrodt Pharmaceuticals
    • Pfizer Inc.
    • Rhodes Pharmaceuticals L.P.
    • Sun Pharmaceutical Industries Limited
    • Nesher Pharmaceuticals (USA) LLC
    • Amneal Pharmaceuticals LLC
    • Trevena Inc.
    • Aurobindo Pharma Limited

11. Section

  • References
  • Research Methodology
  • About us and Sales Contact